TP53 and neoplasm: Similarly, IDH1 mutations also did not increase tumor incidence in Tp53 mutant mouse model, despite the observation that IDH1 mutations induce pre-cancerous lesions such as proliferative subventricular nodules in one mouse model, but interestingly not in an almost identical other model [23, 25].